Watch Comprehensive Prescribing Information and facts OPDIVO® (nivolumab) is indicated to the treatment of Grownup patients with classical Hodgkin lymphoma (cHL) that has relapsed or progressed right after autologous hematopoietic stem cell transplantation (HSCT) and brentuximab vedotin or immediately after 3 or maybe more strains of systemic ther